- Home
- Automated
- List of product information
- YSP HYOSCINE INJECTION 20MG/ML [SIN16636P]
YSP HYOSCINE INJECTION 20MG/ML [SIN16636P]
Active ingredients: YSP HYOSCINE INJECTION 20MG/ML
Product Info
YSP HYOSCINE INJECTION 20MG/ML
[SIN16636P]
Product information
Active Ingredient and Strength | HYOSCINE N-BUTYLBROMIDE - 20 MG/ML |
Dosage Form | INJECTION, SOLUTION |
Manufacturer and Country | Y.S.P. INDUSTRIES (M) SDN. BHD. - MALAYSIA |
Registration Number | SIN16636P |
Licence Holder | YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | NA |
Indication(s):
YSP Hyoscine Injection 20mg/ml is indicated in acute spasm, as in renal or biliary colic, in radiology for differential diagnosis of obstruction. It also indicated to reduce spasm and pain in pyelography, and in other diagnostic procedures where spasm may be a problem.
Dosage and Administration(s):
YSP Hyoscine Injection 20mg/ml may be administered by Intramuscular or intravenous injection.
Adults
One ampoule (20mg) should be given Im or IV, repeated after half an hour if necessary. Intravenous injection should be performed ‘slowly’ (in rare cases a marked drop in blood pressure and even shock may be produced). When used in endoscopy this dose may need to be repeated more frequently.
Maximum daily dose of 100mg.
Not recommended for children under 12 years old.
Mode of Administration:
Intramuscular or intravenous
Contraindications:
YSP Hyoscine Injection 20mg/ml are contraindicated in patients with:
hypersensitivity to the active substance or to any of the excipients
narrow angle glaucoma
hypertrophy of the prostate with urinary retention
mechanical stenosis in the gastrointestinal tract
paralytical or obstructive ileus
megacolon
tachycardia
myasthenia gravis
YSP Hyoscine Injection 20mg/ml should not be given by intramuscular injection to patients being treated with anticoagulant drugs since intramuscular haematoma may occur.
